牛皮和牛皮性关节炎患者的生物药物切换模式:来自VALORE数据库网络的洞察力
Andrea Spini1, Giorgia Pellegrini1, Ylenia Ingrasciotta1
1Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Expert opinion on biological therapy
|May 20, 2024
概括
患有牛皮 (PsO) 和牛皮性关节炎 (PsA) 的患者切换生物药物,特别是TNF-α抑制剂,这样做更快,更频繁. 反IL疗法与更少的开关有关,表明潜在的治疗稳定性.
科学领域:
- 皮肤病学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 在牛皮 (PsO) 和牛皮性关节炎 (PsA) 中切换生物疗法具有临床复杂性.
- 在原始物和生物类似物之间以及不同药物类别之间的过渡需要仔细考虑.
研究的目的:
- 描述PsO/PsA患者的生物切换模式.
- 识别与多次治疗切换和恢复先前治疗 (回切换) 相关的预测因素.
主要方法:
- 一项大规模的回顾性队列研究利用了意大利VALORE数据库.
- 包括在内的是2010年至2022年期间接受治疗的PsO/PsA生物原始患者.
- 分析的重点是切换/交换的时间以及多个切换和回切换的预测因素.
主要成果:
- 分析了超过3万名生物素朴患者;47.8%的患者在5年内至少经历过一次切换/交换.
- 瘤坏死因子-α (TNF-α) 抑制剂的初次切换的中位数时间较短 (2,068天),相比于抗介质素 (anti-IL) 疗法 (2,780天).
- 与那些开始TNF-α抑制剂的患者相比,开始抗IL-12/23治疗的患者的多重切换和回切换风险较低.
结论:
- 在PsO/PsA患者的生物切换模式显示出基于初始治疗的差异.
- 与抗IL药物相比,TNF-α抑制剂与更快,更频繁的切换有关.
- 启动抗IL疗法可能会导致更长的治疗持续时间和减少多次切换的风险.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Antipsychotic Drugs: Typical and Atypical Agents
185
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
185
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K


